PREVENTNCT07257289
Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease
StatusRecruiting
PhaseNot specified
SponsorNantes University Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Interventions modified
- Secondary endpoints: details revised at 1 of 2 entries
- Study description expanded, about 6 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary completion date: Jan 1, 2036 to Feb 3, 2036
- Start date changed from estimate of Feb 1, 2026 to Feb 3, 2026
- Site details revised at 15 of 15 sites
- Notable Start date: Jan 1, 2026 to Feb 1, 2026
- Eligibility criteria shortened, about 53 words
- Study sites: 14 to 15
- Study description expanded, about 7 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arrhythmic and heart failure risk stratification
Timeframe: 5, 8 and 10 years
Secondary (2)
Demographics data
Diagnosis of Brugada syndrome
Arms and interventions
Biologicals: Blood sample
Sites
15 sites in 3 countries
France 13, Martinique 1, Reunion 1